Pfizer asks US to authorise Covid pill

United States pharmaceutical company Pfizer on Tuesday asked regulators to authorise its Covid pill after it was shown to cut hospitalisation or death by nearly 90% among newly infected high-risk patients. The move comes a few weeks after Merck also approached the Food and Drug Administration seeking a green light for its antiviral capsule against the coronavirus.